Ablation, Atrial Flutter and Pulmonary

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

DAIC

JANUARY 31, 2024

Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e.,

Ablation

Ablation Atrial Fibrillation Anatomy Pulmonary

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.

Atrial Fibrillation

Atrial Fibrillation Ablation Atrial Flutter Blood Clot

PO-04-159 INITIAL CLINICAL ASSESSMENT OF ABLATION USING A NOVEL DUAL-PURPOSE PULSED ABLATION CATHETER FOR TYPICAL ATRIAL FLUTTER: CASE REPORT

HeartRhythm

APRIL 30, 2024

Single-shot pulsed field ablation (PFA) catheters for pulmonary vein isolation are being studied. However, there is a need to deliver flexible lesions for atrial flutter (AFL) and non-PV ablations.

Atrial Flutter

Atrial Flutter Ablation Pulmonary

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Concomitant Pulmonary Vein Isolation for induced Atrial fibrillation to reduce future risk of atrial fibrillation following Ablation for Isolated Atrial Flutter

HeartRhythm

JANUARY 6, 2025

A significant proportion of patients with isolated atrial flutter (AFL) will develop atrial fibrillation (AF) following cavotricuspid isthmus (CTI) ablation.

Atrial Flutter

Atrial Flutter Atrial Fibrillation Ablation Pulmonary

PO-01-025 PULMONARY ARTERY PRE-MAPPING AND RADIOFREQUENCY ABLATION: A NOVEL METHOD TO FACILITATE LEFT ATRIAL ROOF LINE BLOCK

HeartRhythm

APRIL 30, 2024

Complete and durable block across the left atrial (LA) roof can be integral to ablation of persistent atrial fibrillation (AF) and atypical atrial flutter (AFl). The right pulmonary artery (RPA) is in close proximity to the LA roof, and may provide a vantage for epicardial LA roof mapping and ablation.

Atrial Flutter

Atrial Flutter Ablation Pulmonary Atrial Fibrillation

Empirical superior vena cava electrical isolation guided by quantitative ablation index improves outcomes of radiofrequency catheter ablation for paroxysmal atrial fibrillation

Open Heart

SEPTEMBER 19, 2024

Background The value of empirical superior vena cava isolation (SVCI) following pulmonary vein isolation (PVI) to improve the efficacy of radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation (PAF) remains controversial. RFCA was guided by quantitative AI in both groups. vs 81.5%, p=0.02). 95% CI 0.19

Atrial Fibrillation

Atrial Fibrillation Ablation Atrial Flutter Coronary Artery Disease

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Dr. S. Venkatesan MD

APRIL 28, 2024

Both atria develop from a combination of the primitive atrium, sinus venous, and pulmonary veins.It In contrast to other tachycardias, with atrial fibrillation (AF), the focus is often speculative, and ablation attempts are made accordingly. We know atrial flutters can be confined to one atrium.

Atrial Fibrillation

Atrial Fibrillation Bicuspid/Mitral Pulmonary Ablation

A novel ablation strategy for recurrent atrial fibrillation: Fractionated signal area in the atrial muscle ablation 1?year follow?up

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

FAAM ablation successfully decreased the recurrence rate of atrial tachyarrhythmia compared with conventional non-PV foci ablation. Abstract Introduction Treatment of recurrent atrial fibrillation (AF) is sometimes challenging due to non-pulmonary vein (PV) foci.

Ablation

Ablation Atrial Fibrillation Atrial Flutter Tachycardia

Very high?power short?duration catheter ablation for treatment of cardiac arrhythmias: Insights from the FAST and FURIOUS study series

Journal of Cardiovascular Electrophysiology

OCTOBER 19, 2023

Abstract The QDOT MICRO™ Catheter is a novel open-irrigated contact force-sensing radiofrequency ablation catheter. It offers very high-power short-duration (vHPSD) ablation with 90 W for 4 s to improve safety and efficacy of catheter ablation procedures.

Arrhythmia

Arrhythmia Ablation Atrial Flutter Atrial Fibrillation

EP News: Case Reports

HeartRhythm

OCTOBER 3, 2023

Pulmonary vein isolation (PVI) remains the cornerstone of atrial fibrillation (AF) ablation. In patients with more advanced AF subtypes, atypical atrial flutter, and extensive atrial myopathy, additional linear ablation is often required; however, durable block of these remains challenging.

Atrial Flutter

Atrial Flutter Atrial Fibrillation Ablation Pulmonary

A young woman with palpitations. What med is she on? With what medication is she non-compliant? What management?

Dr. Smith's ECG Blog

DECEMBER 24, 2023

Atrial flutter with 2:1 conduction. The atrial flutter rate is approximately 200 bpm, with 2:1 AV conduction resulting in ventricular rate almost exactly 100 bpm. Further history revealed she had new onset atrial flutter soon after her aortic surgery, and was put on flecainide approximately 1 month ago.

Atrial Flutter

Atrial Flutter Blog Aortic Aortic valve

Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA).

Ablation

Ablation Atrial Fibrillation Atrial Flutter Pulmonary

Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Introduction The safety and efficacy of paroxysmal atrial fibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. The primary safety endpoint was the occurrence of early-onset primary adverse events (PAEs).

Atrial Fibrillation

Atrial Fibrillation Quality of Life Atrial Flutter Ablation

Medtronic Receives FDA Approval of Mapping and Ablation System and Catheter

DAIC

OCTOBER 30, 2024

The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.

Ablation

Ablation AFIB Atrial Fibrillation Atrial Flutter

Predictors of Arrhythmia Recurrence After Cryoballoon Ablation for Persistent Atrial Fibrillation: A Sub‐Analysis of the Cryo Global Registry

Journal of Cardiovascular Electrophysiology

JANUARY 27, 2025

ABSTRACT Introduction Freedom from recurrences of atrial tachyarrhythmia (ATA) is suboptimal after pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (PsAF). PsAF patients ( N =882) were on average 63.911.3 years old (69.2% male), and freedom from ATA recurrence was 79.7% (76.8%82.2%).

Atrial Fibrillation

Atrial Fibrillation Ablation Atrial Flutter Arrhythmia

Cardiovascular Update

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

PO-04-159 INITIAL CLINICAL ASSESSMENT OF ABLATION USING A NOVEL DUAL-PURPOSE PULSED ABLATION CATHETER FOR TYPICAL ATRIAL FLUTTER: CASE REPORT

Webinars

Concomitant Pulmonary Vein Isolation for induced Atrial fibrillation to reduce future risk of atrial fibrillation following Ablation for Isolated Atrial Flutter

PO-01-025 PULMONARY ARTERY PRE-MAPPING AND RADIOFREQUENCY ABLATION: A NOVEL METHOD TO FACILITATE LEFT ATRIAL ROOF LINE BLOCK

Empirical superior vena cava electrical isolation guided by quantitative ablation index improves outcomes of radiofrequency catheter ablation for paroxysmal atrial fibrillation

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

A novel ablation strategy for recurrent atrial fibrillation: Fractionated signal area in the atrial muscle ablation 1?year follow?up

Very high?power short?duration catheter ablation for treatment of cardiac arrhythmias: Insights from the FAST and FURIOUS study series

EP News: Case Reports

A young woman with palpitations. What med is she on? With what medication is she non-compliant? What management?

Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform

Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study

Medtronic Receives FDA Approval of Mapping and Ablation System and Catheter

Predictors of Arrhythmia Recurrence After Cryoballoon Ablation for Persistent Atrial Fibrillation: A Sub‐Analysis of the Cryo Global Registry

Stay Connected